Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care
Tóm tắt
Family history of breast and related cancers can indicate increased breast cancer (BC) risk. In national familial breast cancer (FBC) guidelines, the risk is stratified to guide referral decisions. We aimed to identify characteristics associated with the recommendation for referral in a large cohort of women undergoing FBC risk assessment in a recent primary care study. Demographic, family history, psychological and behavioural factors were collected with family history questionnaires, psychological questionnaires and manual data extraction from general practice electronic health records. Participants were women aged 30–60 with no previous history of breast or ovarian cancer. Data from 1127 women were analysed with stepwise logistic regression. Two multivariable logistic models were developed to predict recommendations for referral: using the entire cohort (n = 1127) and in a subgroup with uncertain risks (n = 168). Model performance was assessed by the area under the receiver operating curve (AUC). In all 1127 women, a multivariable model incorporating five family history components (BC aged < 40, bilateral BC, prostate cancer, first degree relative with ovarian cancer, paternal family history of BC) and having a mammogram in the last 3 years, performed well (AUC = 0.86). For the 168 uncertain risk women, only paternal family history of BC remained significant (AUC = 0.71). Clinicians should pay particular attention to these five family history components when assessing FBC risk, especially prostate cancer which is not in the current national guidelines.
Tài liệu tham khảo
American Cancer Society (2019) About breast cancer: how common is breast cancer? https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html. Accessed 4th March 2019
Amir E, Evans DG, Shenton A et al (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40(11):807–814
Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS et al (2015) Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women’s Health Initiative study. Cancer 121(8):1265–1272
Cancer Research UK (2014) Breast cancer risk: family history and genetic factors. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/risk-factors?_ga=2.79490193.40239941.1551692733-497498739.1502785473#heading-Six. Accessed 4th march 2019
Cancer Research UK (2018a) Inherited genes and cancer types: prostate cancer. https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/inherited-cancer-genes-and-increased-cancer-risk/inherited-genes-and-cancer-types#inherited_genes6. Accessed 4th march 2019
Cancer Research UK (2018b) Inherited genes and cancer types. https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/inherited-cancer-genes-and-increased-cancer-risk/inherited-genes-and-cancer-types#inherited_genes1. Accessed 18th October 2018
Carbine NE, Lostumbo L, Wallace J, Ko H (2018) Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev 4:CD002748
Chorley W, Dutton B, Brindley C, Robles L, Qureshi N (2016) From national guideline recommendations to familial cancer risk assessment decision support in primary care: UK experience. https://www.nottingham.ac.uk/research/groups/primarycarestratifiedmedicine/documents/prism-familial-breast-cancer-poster-eshg-2016.pdf. Accessed 31st October 2018
Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399
Cuzick J, Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix A, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL, SERM Chemoprevention of Breast Cancer Overview Group et al (2013) Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 381(9880):1827–1834
Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, van t'veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975
Duffy SW, Mackay J, Thomas S et al (2013) Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study. Health Technol Assess 17(11):vii–xiv 1-95
Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick J, Buchan I, Donnelly LS, Howell A et al (2014) Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev Res 7(10):993–1001
Gorman Á, Sugrue M, Ahmed Z, Johnston A (2014) An evaluation of FaHRAS computer programmes’ utility in family history triage of breast cancer. Adv Breast Cancer Res 3:17–21
Lerman C, Track B, Rimer BK, Boyce A, Jepson C, Engstrom PF (1991) Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 114(8):657–661
Mathur R, Bhaskaran K, Chaturvedi N et al (2014) Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf) 36(4):684–692
Murff HJ, Byrne D, Syngal S (2004) Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 27(3):239–245
National Institute for Health and Care Excellence (2013) Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer [CG164]. https://www.nice.org.uk/guidance/cg164/chapter/Recommendations#terms-used-in-this-guideline. Accessed 9th October 2018
NIHR SPCR (2013) Phase 2 – proactive familial breast cancer risk assessment in primary care: feasibility of an optimised intervention to improve identification. https://www.spcr.nihr.ac.uk/projects/phase-2-proactive-familial-breast-cancer-risk-assessment-in-primary-care-feasibility-of-an-optimised-intervention-to-improve-identification. Accessed 22nd May 2019
Office for National Statistics (2010) SOC2010 volume 1: structure and descriptions of unit groups. 4.2 Major group structure of the classification and qualifications, skills, training and experience. http://webarchive.nationalarchives.gov.uk/20160106225424/http://www.ons.gov.uk/ons/guide-method/classifications/current-standard-classifications/soc2010/soc2010-volume-1-structure-and-descriptions-of-unit-groups/index.html. Accessed 4th March 2019
Office for National Statistics (2012) 2011 Census: Key Statistics for local authorities in England and Wales. Table KS201EW: Ethnic group, local authorities in England and Wales
Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379
Petrucelli N, Daly MB, Pal T (1998) BRCA1- and BRCA2-associated hereditary breast and ovarian cancer. In: Adam MP, Ardinger HH, Pagon RA et al (eds) GeneReviews®. University of Washington, Seattle
Qureshi N, Bethea J, Modell B et al (2005) Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 22(6):663–669
Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto
Tyler CV Jr, Snyder CW (2006) Cancer risk assessment: examining the family physician’s role. J Am Board Fam Med 19(5):468–477
Warwick Institute for Employment Research (2018) Cascot: computer assisted structured coding tool. https://warwick.ac.uk/fac/soc/ier/software/cascot/details/. Accessed 10th April 2018
World Cancer Research Fund (2018) Global cancer incidence in women. https://www.wcrf.org/dietandcancer/cancer-trends/worldwide-cancer-data. Accessed 18th October 2018